Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholan... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
0
Authors
Ghassan Abou‐Alfa
28 more
Ghassan Abou‐Alfa
•
Longying Jiang
26 more
•
Andrew Zhu
Published
May 13, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Biology
Biochemistry
Physics
Chemistry
Medicine
Show all topics
DOI
10.1016/s1470-2045(20)30157-1
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Biology
Biochemistry
Physics
Chemistry
Medicine
Show all topics
DOI
10.1016/s1470-2045(20)30157-1
Other Formats
PDF
